Arylpiperazines as fatty acid transport protein 1 (FATP1) inhibitors with improved potency and pharmacokinetic properties.

T. Matsufuji,M. Ikeda,A. Naito,Masakazu Hirouchi,S. Kanda,Masanori Izumi,J. Harada,T. Shinozuka
DOI: https://doi.org/10.1016/j.bmcl.2013.02.116
IF: 2.94
2013-05-01
Bioorganic & Medicinal Chemistry Letters
Abstract:
What problem does this paper attempt to address?